Carbidopa

Common Brands Lodosyn
Drug Class
Decarboxylase inhibitor
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Availability
Prescription only
Kristianne Hannemann, PharmD
Kristianne Hannemann, PharmD
Read More
Medically reviewed by Kristianne Hannemann, PharmD last update on 20/12/2023

Overview

Carbidopa is a medication commonly used in the treatment of Parkinson’s disease and other movement disorders. It is often prescribed in combination with levodopa, a medication that the body converts into dopamine, a neurotransmitter that is deficient in patients with Parkinson’s disease. Carbidopa’s primary function is to prevent the premature conversion of levodopa into dopamine outside of the brain, thereby allowing more levodopa to reach the brain where it is needed.

Parkinson’s disease is a neurodegenerative disorder that affects motor function, leading to symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. Levodopa is considered one of the most effective treatments for the motor symptoms of Parkinson’s disease, but its effectiveness is limited by side effects, particularly nausea and vomiting. Carbidopa plays a crucial role in improving the efficacy and reducing these side effects, allowing for better management of the disease.

Carbidopa is most commonly found in combination with levodopa in medications such as Sinemet, which is prescribed to patients with Parkinson’s disease. The combination of these two drugs works synergistically to reduce the motor symptoms of Parkinson’s disease while minimizing unwanted side effects.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy